Revolution Medicines, Inc.

Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial f…

Biotechnology

US, Redwood City [HQ]

Competitors · Subsidiaries · Locations

Context Analysis

Competitors · Subsidiaries · Locations

The Contextualizer is eligible to "contextualize" the market relationships of Revolution Medicines, Inc.,
e.g. through tracking it's acquisitions, subsidiaries, offices, fabrics and competitors around the globe.

Tip: If you see a dot, it's always worth scrolling up so that the map enlarges and points on top of each other (e.g. NYC vs. Fort Lee) can be differentiated.

U.S. · Business Intelligence

The U.S. map and table tracks offices, fabrics, competitors and subsidiaries located in the United States.

Worldwide · Business Intelligence

The worldwide map and table tracks NON-US offices, fabrics, competitors and subsidiaries.

Worldwide · Competitors Table

Sourced from FMP or manual.

Competitor	Private?	Source	Accuracy	Country	City
Akero Therapeutics, Inc.		FMP	High	United States	South San Francisco
Blueprint Medicines Corporation		FMP	High	United States	Cambridge

Worldwide · Subsidiaries Table

Sourced from the SEC, through government awards and manual entries.

Subsidiary	Private?	Country	City
-	-	-	-